Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2016-02-29
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After completion of re-evaluation, a final report will be made and send to both patient and primary care physician with recommendations for further follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort of Hepatitis B Research of Amsterdam
NCT01462981
Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India
NCT01772121
Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.
NCT00263614
Hepatitis B Research Network Adult Cohort Study
NCT01263587
Collections of Blood and Stool Samples in Patients With Acute Hepatitis
NCT00001879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic hepatitis B
Patients diagnosed with chronic hepatitis B
No interventions assigned to this group
Chronic hepatitis C
Patients diagnosed with chronic hepatitis C
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of chronic hepatitis C (two positive anti-HCV with an interval of 6 months)
Exclusion Criteria
* Cured from chronic HBV or chronic HCV
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gilead Sciences
INDUSTRY
Stichting MDL Holland-Noord
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Klemt-Kropp, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Stichting MDL Holland-Noord
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL-174-2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.